Overview Financials News + Filings Key Docs Charts Insiders
|
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Nutritional Products | 22.1 | 19.1 | 18.8 | 21.6 | 21.6 | | | |
| Medical Products | 2.8 | 6.4 | 6.3 | 4.0 | 6.5 | | | |
| Other | 3.4 | | | 2.8 | | | | |
| Total revenues | 28.3 | 25.5 | 25.2 | 28.4 | 28.2 | 24.9 | 30.4 | 27.0 |
| Revenue growth [+] | 11.0% | 1.2% | -11.6% | 1.0% | 13.0% | -18.0% | 12.5% | 24.6% |
| Nutritional Products | 15.7% | 1.3% | -12.7% | -0.1% | | | | |
| Medical Products | -55.9% | 1.0% | 56.4% | -38.2% | | | | |
| Cost of goods sold | 12.6 | 13.5 | 12.5 | 14.1 | 14.5 | 12.1 | 14.9 | 12.1 |
| Gross profit | 15.6 | 12.0 | 12.6 | 14.3 | 13.7 | 12.8 | 15.5 | 14.9 |
| Gross margin | 55.3% | 47.2% | 50.2% | 50.3% | 48.6% | 51.4% | 51.0% | 55.1% |
| Selling, general and administrative [+] | 15.8 | 12.1 | 13.0 | 13.9 | 12.2 | 12.6 | 10.0 | 9.1 |
| Sales and marketing | 4.7 | 2.8 | 3.2 | 4.3 | 2.9 | 2.5 | | |
| General and administrative | 11.1 | 9.3 | 9.8 | 9.6 | 9.2 | 10.1 | 10.0 | 9.1 |
| Other operating expenses | | | -0.4 | | | | 2.6 | 2.9 |
| EBITDA [+] | 0.0 | 0.0 | 0.1 | 0.4 | 1.6 | 0.3 | 3.2 | 3.3 |
| EBITDA growth | 24.8% | -130.0% | -72.2% | -72.5% | 434.8% | -90.8% | -1.1% | 103.7% |
| EBITDA margin | -0.2% | -0.1% | 0.5% | 1.5% | 5.6% | 1.2% | 10.6% | 12.1% |
| Depreciation | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 |
| EBITA | -0.6 | -0.6 | -0.5 | -0.1 | 1.0 | -0.2 | 2.9 | 2.9 |
| EBITA margin | -2.1% | -2.4% | -1.8% | -0.2% | 3.7% | -0.6% | 9.4% | 10.7% |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | | | | |
| EBIT [+] | -0.6 | -0.6 | -0.5 | -0.1 | 1.0 | -0.2 | 2.9 | 2.9 |
| EBIT growth | 0.1% | 34.7% | 554.0% | -106.8% | -753.9% | -105.6% | -1.6% | 200.0% |
| EBIT margin | -2.2% | -2.5% | -1.8% | -0.2% | 3.7% | -0.6% | 9.4% | 10.7% |
| Interest expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Pre-tax income | -0.7 | -0.7 | -0.6 | -0.2 | 0.9 | -0.3 | 2.7 | 2.7 |
| Income taxes | -0.1 | -0.2 | -0.2 | -0.1 | 0.3 | 0.0 | 1.1 | 1.0 |
| Tax rate | 16.4% | 32.1% | 38.7% | 66.1% | 37.4% | | 39.6% | 37.1% |
| Net income | -0.6 | -0.5 | -0.4 | -0.1 | 0.6 | -0.3 | 1.6 | 1.7 |
| Net margin | -2.1% | -2.0% | -1.4% | -0.3% | 2.0% | -1.3% | 5.3% | 6.3% |
| |
| Basic EPS [+] | ($0.27) | ($0.23) | ($0.16) | $0.00 | $0.03 | ($0.02) | $0.08 | $0.08 |
| Growth | 20.9% | 38.6% | 4955.5% | -112.7% | -266.0% | -120.3% | -9.3% | 283.5% |
| Diluted EPS [+] | ($0.27) | ($0.23) | ($0.16) | $0.00 | $0.02 | ($0.02) | $0.07 | $0.08 |
| Growth | 20.9% | 38.6% | 4955.5% | -112.9% | -262.7% | -121.6% | -7.2% | 285.2% |
| |
| Shares outstanding (basic) [+] | 2.2 | 2.2 | 2.2 | 22.2 | 22.0 | 21.9 | 21.5 | 20.4 |
| Growth | -0.3% | -0.2% | -90.0% | 1.0% | 0.4% | 2.1% | 5.2% | 1.2% |
| Shares outstanding (diluted) [+] | 2.2 | 2.2 | 2.2 | 22.2 | 22.4 | 21.9 | 22.8 | 22.2 |
| Growth | -0.3% | -0.2% | -90.0% | -0.9% | 2.3% | -4.0% | 2.8% | 0.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|